 |
Articles: Financial Reports |
Solvay will early close its public offering of a 6 year bond for a total amount of EUR 500 million
Solvay, 05/21/09
Free full text
Cytokinetics Announces Registered Direct Common Stock Offering of $14.0 Million
Cytokinetics, 05/20/09
Free full text
Medtronic Annual Revenue Up 8 Percent to $14.6 Billion
Medtronic, 05/20/09
Free full text
Ambrilia reports first quarter 2009 results
Ambrilia Biopharma, 05/18/09
Free full text
Public offering of a 6 year bond bearing interest at 5.0 % issued by Solvay S.A. for an expected amount of minimum EUR 150 million
Solvay, 05/18/09
Free full text
Protox reports 2009 first quarter results
Protox Therapeutics, 05/18/09
Free full text
Gilead Palo Alto, Inc. Announces Tender Offer for Convertible Notes
Gilead, 05/15/09
Free full text
DeCODE genetics Announces First Quarter 2009 Financial Results
deCODE genetics, 05/15/09
Free full text
DeCODE genetics Announces Full-year 2008 Financial Results
deCODE genetics, 05/15/09
Free full text
DeCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results
deCODE genetics, 05/15/09
Free full text
DeCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results
deCODE genetics, 05/15/09
Free full text
CareFusion names Edward Borkowski as chief financial officer
Cardinal Health, 05/14/09
Free full text
"Corporate strategy proves effective in a difficult environment"
BayNews International, 05/13/09
Free full text
Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
Cell Therapeutics, 05/13/09
Free full text
AVI BioPharma Announces First Quarter 2009 Financial Results
AVI BioPharma, 05/12/09
Free full text
Avigen Reports First Quarter 2009 Financial Results
Avigen, 05/12/09
Free full text
Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $20 Million of Common Stock and Warrants
Cell Therapeutics, 05/12/09
Free full text
King Pharmaceuticals Reports First-Quarter 2009 Financial Results
King Pharmaceuticals, 05/12/09
Free full text
Certain Salix Officers and Directors Adopt 10b5-1 Trading Plans for Stock Options that are Scheduled to Expire During 2010
Salix Pharmaceuticals, 05/12/09
Free full text
DeCODE genetics Announces First Quarter 2009 Financial Results
deCODE genetics, 05/12/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
146 Available Pages
|
|
